期刊
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM
卷 3, 期 2, 页码 122-133出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/ncpendmet0388
关键词
calcimimetic; calcium-sensing receptor; CaR; hyperparathyroidism; parathyroid hormone
The extracellular calcium ion (Ca2+ (e))-sensing receptor (CaR) enables key tissues that maintain Ca2+ (e) homeostasis to sense changes in the Ca2+ (e) concentration. These tissues respond to changes in Ca2+ (e) with functional alterations that will help restore Ca2+ (e) to normal. For instance, decreases in Ca2+ (e) act via the CaR to stimulate secretion of parathyroid hormone - a Ca2+ (e)- elevating hormone - and to increase renal tubular calcium reabsorption; each response helps promote normalization of Ca2+ (e) levels. Further work is needed to determine whether the CaR regulates other parameters of renal function ( e. g. 1,25-dihydroxyvitamin D-3 synthesis, intestinal absorption of mineral ions, and/or bone turnover). Identification of the CaR has also elucidated the pathogenesis and pathophysiology of inherited disorders of mineral and electrolyte metabolism; moreover, acquired abnormalities of Ca2+ (e)- sensing can result from autoimmunity to the CaR, and reduced CaR expression in the parathyroid may contribute to the abnormal parathyroid secretory control that is observed in primary and secondary hyperparathyroidism. Finally, calcimimetics - allosteric activators of the CaR - treat secondary hyperparathyroidism effectively in end-stage renal failure.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据